GEN Exclusives

More »

GEN Poll

More »
Jun 06, 2014

DTC Testing Regulation

In a recent survey, the Science Advisory Board asked 500 of its U.S. members to share their views on the direct-to-consumer (DTC) testing industry, specifically in the context of the FDA's warning letter to 23andMe back in November of 2013. (You can see the results of that survey here.) What are your thoughts on the issue?

Should the FDA further extend regulations regarding DTC testing technologies?

Yes, there is a significant lack of regulation in this area
 
  32.3%
Yes, but only for a subset of these products
 
  21.6%
No, it would have a negative effect on these innovations
 
  10.8%
No, consumers should have access to as much personalized medical info as possible
 
  35.3%

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using Pet Dogs with Cancer in Preclinical Trials

Do you agree that pet dogs with cancer should be used in early cancer drug trials?

More »